Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy

Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy

Recent evidence suggests that myeloid cells are critical in cancer development and therapy resistance processes. Pharmacological targeting of tumor-associated myeloid cells is an emerging approach among upcoming immune therapies. Surprisingly, myeloid cells are heterogeneous, including a subset of t...

Full description

Bibliographic Details
Main Authors: Benjamin W. Johnson, Bhagelu R. Achyut, Sadanand Fulzele, Ashis K. Mondal, Ravindra Kolhe, Ali S. Arbab
Format: Article
Language:English
Published: MDPI AG 2018-08-01
Series:International Journal of Molecular Sciences
Subjects:
angiogenic
myeloid
chemotherapy
radiotherapy
immunotherapy
antiangiogenic
MDSC
tumor
Online Access:http://www.mdpi.com/1422-0067/19/9/2565

Internet

http://www.mdpi.com/1422-0067/19/9/2565

Similar Items